In silico design of anti-atherogenic biomaterials

Biomaterials

Volumn 34, Issue 32, 2013, Pages 7950-7959

  Lewis, Daniel R ^a   Kholodovych, Vladyslav ^d,e   Tomasini, Michael D ^b,f   Abdelhamid, Dalia ^c   Petersen, Latrisha K ^b   Welsh, William J ^d   Uhrich, Kathryn E ^c   Moghe, Prabhas V ^a,b  

^a The State University of New Jersey   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c State University of New Jersey   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^f ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Amphiphilic macromolecules; Atherosclerosis; Macrophages; Molecular modeling; Structure activity relations

Indexed keywords

AMPHIPHILIC MACROMOLECULES; ANTI-ATHEROGENIC ACTIVITIES; ATHEROSCLEROSIS; COARSE-GRAINED MOLECULAR DYNAMICS; HUMAN MONOCYTE-DERIVED MACROPHAGES; MOLECULAR CONNECTIVITY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS; STRUCTURE-ACTIVITY RELATION;

CHEMICAL VAPOR DEPOSITION; DESIGN; DISEASES; LIPOPROTEINS; MACROMOLECULES; MACROPHAGES; MOLECULAR MODELING; POLYETHYLENE GLYCOLS;

BIOLOGICAL MATERIALS;

AMPHOPHILE; BIOMATERIAL; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CHEMICAL MODIFICATION; COMPUTER MODEL; COMPUTER SIMULATION; CONFORMATION; CONTROLLED STUDY; EQUIPMENT DESIGN; FOAM CELL; GEOMETRY; HUMAN; HUMAN CELL; MACROMOLECULE; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SCREENING; STEREOCHEMISTRY; THREE DIMENSIONAL IMAGING;

EID: 84881029509     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.011     Document Type: Article

References (61)

1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105(9):1135-1143.
2. Sahoo D., Drover V. The role of scavenger receptors in signaling, inflammation and atherosclerosis. Biochemistry of atherosclerosis 2006, 70-91. Springer, US. S. Cheema (Ed.).
3. Fuhrman B., Partoush A., Volkova N., Aviram M. Ox-LDL induces monocyte-to-macrophage differentiation invivo: possible role for the macrophage colony stimulating factor receptor (M-CSF-R). Atherosclerosis 2008, 196(2):598-607.
4. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996, 20(5):707-727.
5. Boyle J.J. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 2005, 3:63-68.
6. Gotto A.M. Antioxidants, statins, and atherosclerosis. JAm Coll Cardiol 2003, 41(7):1205-1210.
7. Saha P., Modarai B., Humphries J., Mattock K., Waltham M., Burnand K.G., et al. The monocyte/macrophage as a therapeutic target in atherosclerosis. Curr Opin Pharmacol 2009, 9(2):109-118.
8. Hehir S., Plourde N.M., Gu L., Poree D.E., Welsh W.J., Moghe P.V., et al. Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A. Acta Biomater 2012, 8(11):3956-3962.
9. Iverson N.M., Plourde N.M., Sparks S.M., Wang J., Patel E.N., Shah P.S., et al. Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation. Biomaterials 2011, 32(32):8319-8327.
10. Iverson N.M., Sparks S.M., Demirdirek B., Uhrich K.E., Moghe P.V. Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers. Acta Biomater 2010, 6(8):3081-3091.
11. Wang J., Plourde N.M., Iverson N., Moghe P., Uhrich K.E. Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture. Int J Nanomedicine 2007, 2(4):697-705.
12. Plourde N.M., Kortagere S., Welsh W., Moghe P.V. Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A. Biomacromolecules 2009, 10(6):1381-1391.
13. Chnari E., Nikitczuk J.S., Wang J., Uhrich K.E., Moghe P.V. Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages. Biomacromolecules 2006, 7(6):1796-1805.
14. Chnari E., Nikitczuk J.S., Uhrich K.E., Moghe P.V. Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. Biomacromolecules 2006, 7(2):597-603.
15. Chnari E., Lari H.B., Tian L., Uhrich K.E., Moghe P.V. Nanoscale anionic macromolecules for selective retention of low-density lipoproteins. Biomaterials 2005, 26(17):3749-3758.
16. Mayr L.M., Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009, 9(5):580-588.
17. Wang C.Y., Ai N., Arora S., Nagarajan K., Zauhar R., Young D., et al. Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach. Chem Res Toxicol 2006, 19(12):1595-1601.
18. Chekmarev D., Kholodovych V., Kortagere S., Welsh W., Ekins S. Predicting inhibitors of acetylcholinesterase by regression and classification machine learning approaches with combinations of molecular descriptors. Pharm Res 2009, 26(9):2216-2224.
19. Paranjpe P.V., Chen Y., Kholodovych V., Welsh W., Stein S., Sinko P.J. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and invitro evaluation. JControl Release 2004, 100(2):275-292.
20. Passic S.R., Ferguson M.L., Catalone B.J., Kish-Catalone T., Kholodovych V., Zhu W., et al. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1. Biomed Pharmacother 2010, 64(10):723-732.
21. Kortagere S., Welsh W. Development and application of hybrid structure based method for efficient screening of ligands binding to g-protein coupled receptors. JComput Aided Mol Des 2006, 20(12):789-802.
22. Aparoy P., Kumar Reddy K., Reddanna P. Structure and ligand based drug design strategies in the development of novel 5-lox inhibitors. Curr Med Chem 2012, 19(22):3763-3778.
23. Hsieh J.H., Yin S., Wang X.S., Liu S., Dokholyan N.V., Tropsha A. Cheminformatics meets molecular mechanics: a combined application of knowledge-based pose scoring and physical force field-based hit scoring functions improves the accuracy of structure-based virtual screening. JChem Inf Model 2011, 52(1):16-28.
24. Mize C.D., Abbott A.M., Gacasan S.B., Parrill A.L., Baker D.L. Ligand-based autotaxin pharmacophore models reflect structure-based docking results. JMol Graph Model 2011, 31(0):76-86.
25. Bhatt H.G., Patel P.K. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors. Bioorg Med Chem Lett 2012, 22(11):3758-3765.
26. Sushko I., Novotarskyi S., Körner R., Pandey A., Rupp M., Teetz W., et al. Online chemical modeling environment (ochem): web platform for data storage, model development and publishing of chemical information. JComput Aided Mol Des 2011, 25(6):533-554.
27. Dube D., Periwal V., Kumar M., Sharma S., Singh T., Kaur P. 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors. JMol Model 2012, 18(5):1701-1711.
28. Dong X.O., Ebalunode J., Yang S.-Y., Zheng W. Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling. Curr Comput Aided Drug Des 2011, 7(3):181-189.
29. Ebalunode J., Zheng W., Tropsha A. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design. Chemical library design. Methods in molecular biology 2011, vol. 685:111-133. Humana Press.
30. Kooistra A.J., Roumen L., Leurs R., de Esch I.J., de Graaf C. From heptahelical bundle to hits from the haystack: structure-based virtual screening for GPCR ligands. Meth Enzymol 2013, 522:279-336.
31. Kamal A., Kashi Reddy M., Viswanath A. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs. Expert Opin Drug Discov 2013, 8(3):289-304.
32. Krasowski M.D., Hopfinger A.J. The discovery of new anesthetics by targeting GABAA receptors. Expert Opin Drug Discov 2011, 6(11):1187-1201.
33. Martin T.M., Harten P., Young D.M., Muratov E.N., Golbraikh A., Zhu H., et al. Does rational selection of training and test sets improve the outcome of QSAR modeling?. JChem Inf Model 2012, 52(10):2570-2578.
34. Ertl P., Lewis R. Iade: a system for intelligent automatic design of bioisosteric analogs. JComput Aided Mol Des 2012, 26(11):1207-1215.
35. Gubskaya A.V., Kholodovych V., Knight D., Kohn J., Welsh W.J. Prediction of fibrinogen adsorption for biodegradable polymers: integration of molecular dynamics and surrogate modeling. Polymer 2007, 48(19):5788-5801.
36. Smith J.R., Knight D., Kohn J., Rasheed K., Weber N., Kholodovych V., et al. Using surrogate modeling in the prediction of fibrinogen adsorption onto polymer surfaces. JChem Inf Comput Sci 2004, 44(3):1088-1097.
37. Duan P., Li S., Ai N., Hu L., Welsh W.J., You G. Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization. Mol Pharmacol 2012, 9(11):3340-3346.
38. Fomovska A., Wood R.D., Mui E., Dubey J.P., Ferreira L.R., Hickman M.R., et al. Salicylanilide inhibitors of toxoplasma gondii. JMed Chem 2012, 55(19):8375-8391.
39. Tian L., Yam L., Zhou N., Tat H., Uhrich K.E. Amphiphilic scorpion-like macromolecules: design, synthesis, and characterization. Macromolecules 2004, 37(2):538-543.
40. Djordjevic J., del Rosario L.S., Wang J., Uhrich K.E. Amphiphilic scorpion-like macromolecules as micellar nanocarriers. JBioact Compat Polym 2008, 2008(23):532-551.
41. Wang J., del Rosario L.S., Demirdirek B., Bae A., Uhrich K.E. Comparison of peg chain length and density on amphiphilic macromolecular nanocarriers: self-assembled and unimolecular micelles. Acta Biomater 2009, 5:883-892.
42. Case D.A., Darden T.A., Cheatham T.E., Simmerling C.L., Wang J., Duke R.E., et al. Amber 12 2012, University of California, San Francisco.
43. Marrink S.J., Risselada H.J., Yefimov S., Tieleman D.P., de Vries A.H. The MARTINI force field: coarse grained model for biomolecular simulations. JPhys Chem B 2007, 111(27):7812-7824.
44. Monticelli L., Kandasamy S.K., Periole X., Larson R.G., Tieleman D.P., Marrink S.-J. The MARTINI coarse-grained force field: extension to proteins. JChem Theory Comput 2008, 4(5):819-834.
45. Lee H., de Vries A.H., Marrink S.-J., Pastor R.W. Acoarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. JPhys Chem B 2009, 113(40):13186-13194.
46. Marrink S.J., de Vries A.H., Mark A.E. Coarse grained model for semiquantitative lipid simulations. JPhys Chem B 2003, 108(2):750-760.
47. Hess B., Kutzner C., van der Spoel D., Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. JChem Theory Comput 2008, 4(3):435-447.
48. Rzepiela A.J., Schäfer L.V., Goga N., Risselada H.J., De Vries A.H., Marrink S.J. Reconstruction of atomistic details from coarse-grained structures. JComput Chem 2010, 31(6):1333-1343.
49. Sousa da Silva A., Vranken W. ACPYPE-AnteChamber PYthon Parser interfacE. BMC Res Notes 2012, 5(1):367.
50. Lewis D.R., Kamisoglu K., York A.W., Moghe P.V. Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3(4):400-420.
51. Iverson N., Plourde N., Chnari E., Nackman G.B., Moghe P.V. Convergence of nanotechnology and cardiovascular medicine. Biodrugs 2008, 22(1):1-10.
52. Mantovani A., Garlanda C., Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 2009, 29(10):1419-1423.
53. Mantovani A., Sica A., Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007, 37(1):14-16.
54. York A.W., Zablocki K.R., Lewis D.R., Gu L., Uhrich K.E., Prud'homme R.K., et al. Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy. Adv Mater 2012, 24(6):733-739.
55. Kou P.M., Pallassana N., Bowden R., Cunningham B., Joy A., Kohn J., et al. Predicting biomaterial property-dendritic cell phenotype relationships from the multivariate analysis of responses to polymethacrylates. Biomaterials 2012, 33(6):1699-1713.
56. Petersen L.K., Ramer-Tait A.E., Broderick S.R., Kong C.-S., Ulery B.D., Rajan K., et al. Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. Biomaterials 2011, 32(28):6815-6822.
57. Ricci R., Sumara G., Sumara I., Rozenberg I., Kurrer M., Akhmedov A., et al. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004, 306(5701):1558-1561.
58. Todeschini R., Lasagni M., Marengo E. New molecular descriptors for 2D and 3D structures. Theory J Chemom 1994, 8(4):263-272.
59. Consonni V., Todeschini R., Pavan M. Structure/response correlations and similarity/diversity analysis by getaway descriptors. 1. Theory of the novel 3D molecular descriptors. JChem Inf Comput Sci 2002, 42(3):682-692.
60. Consonni V., Todeschini R., Pavan M., Gramatica P. Structure/response correlations and similarity/diversity analysis by getaway descriptors. 2. Application of the novel 3D molecular descriptors to QSAR/QSPR studies. JChem Inf Comput Sci 2002, 42(3):693-705.
61. 3D QSAR in drug design 1998, Kluwer/ESCOM, Dordrecht (The Netherlands). H. Kubinyi, G. Folkers, Y.C. Martin (Eds.).